RENALYSE
LIVE

Serial Number

79275407

Owner

CreatSens Health, S.L.

Attorney

Kevin S. Costanza

Filing Date

Nov 28, 2019

Add to watchlist:

No watchlists yet
View on USPTO

RENALYSE Trademark

Serial Number: 79275407 • Registration: 6422167

RENALYSE is a trademark filed by CreatSens Health, S.L. on November 28, 2019. The trademark is classified under Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

CreatSens Health, S.L.

Av. Paisos Catalans, 18

Entity Type: 16

Trademark Details

Filing Date

November 28, 2019

Registration Date

July 20, 2021

Published for Opposition

May 4, 2021

Goods & Services

Downloadable or recorded computer software for managing data and computer files and databases; downloadable software for remote monitoring and analysis of medical equipment to analyze, treat, develop, transfer, communicate and show medical data and recommendations to users; downloadable or recorded application software programs for medical equipment to analyze, treat, develop, transfer, communicate and show medical data and recommendations to users; data processors; apparatus for data processing in real time; downloadable or recorded computer programs relating to the medical field for the analysis, treatment, development, transfer, communication and follow-up of the medical data; downloadable or recorded software for remote diagnostics of the kidney, cardiac disease and personalized treatment; interactive downloadable databases in the field of health and well-being; recorded or downloadable software platforms for medical equipment for data transfer and managing communication channels between physician's or medical staff and other medical staff and patients; scientific instruments for measuring, detecting and monitoring, indicators and controllers, namely, electrochemical analyzer devices to measure, detect and monitor biologic biomarkers in nephrology and cardiology; apparatus for transmitting data, namely, transmitter of electronic signals for medical equipment, specifically for electrochemical devices; downloadable or recorded computer programs relating to the medical field for the analysis, treatment, development, transfer, communication and follow-up of the medical data; instruments for diagnosis, namely, electrochemical devices in the nature of colorimeters, Potentiometric and amperometric electrochemical devices, namely, devices that measure the potential between two electrodes under an open circuit potential for potentiometry and that measure the current when applying a constant polarization voltage for amperometry for scientific use; measuring apparatus, namely, electrochemical devices in the nature of electronic analyzers for testing and analyzing chemical substances for the presence, absence, or quantity of target biomolecules, chemicals, and biologics; sensors and detectors, namely, potentiometric colorimeters and amperometric paper and plastic-based sensors and detectors, namely, potentiometric electronic boards; detection apparatus, namely, electrochemical devices in the nature of electronic analyzers for testing and analyzing chemical substances for the presence, absence, or quantity of target biomolecules, chemicals, and biologics; remote control apparatus, namely, point of care devices, in particular, electronic devices for assisting care giving for seniors and people needing assistance, comprised of sensors for determining status of person and apparatus for sending electronic alerts to care givers; downloadable or recorded artificial intelligence software for health care for managing, monitoring and facilitating specific treatment of patients and recommendations; digital sensory devices, namely, electrochemical and colorimetric, potentiometric, amperometric, and colorimetric transducers; downloadable or recorded interactive software for managing, monitoring and facilitating specific treatment of patients and recommendations; instruments for diagnosis, namely, electrochemical devices in the nature of colorimeters, Potentiometric and amperometric electrochemical devices, namely, devices that measure the potential between two electrodes under an open circuit potential for potentiometry and that measure the current when applying a constant polarization voltage for amperometry for scientific use; apparatus for scientific and laboratory research, namely, electrochemical and colorimetric electric, flow pH, potentiometric, and amperometric meters; educational apparatus and simulators, namely, electrochemical and colorimetric electric, flow pH, potentiometric, amperometric meters

Measuring sensors for measuring nephrological and cardiological biomarkers, for medical use; medical diagnostic instruments for monitoring patients suffering any degree of kidney and/or cardiac disease and for specifying personalized treatments and recommendations; tools for veterinary diagnosis for monitoring the pet with kidney and/or cardiac disease and specifying treatment and recommendations; apparatus for diagnostic testing for medical purposes for a follow-up of patients suffering any degree of kidney and/or cardiac disease, and specifying personalized treatments and recommendations; electronic monitoring apparatus for medical use, namely, point of care devices in the nature of patient monitors for critical care and wearable monitors used to measure biometric data for medical use; medical and veterinary apparatus and instruments, namely, point of care electrochemical devices in the nature of patient monitors for critical care and wearable monitors used to measure biometric data for medical use; detection apparatus for medical use, namely, point of care devices in the nature of patient monitors for critical care and wearable monitors used to measure biometric data for medical use

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 22, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 19, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 1, 2021 FICS
FINAL DISPOSITION PROCESSED
Dec 1, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 20, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 20, 2021 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 20, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 2, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 2, 2021 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 4, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 4, 2021 PUBO
NOTIFICATION PROCESSED BY IB
May 2, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 14, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 14, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 14, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 30, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 10, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 22, 2020 GNFN
FINAL REFUSAL E-MAILED
Sep 22, 2020 GNFR
FINAL REFUSAL WRITTEN
Sep 22, 2020 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 2, 2020 TROA
REFUSAL PROCESSED BY IB
Apr 10, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 24, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 7, 2020 RFCR
NON-FINAL ACTION WRITTEN
Mar 6, 2020 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 11, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 7, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 2, 2020 REPR